Taiho is parting with $400 million upfront for Araris, a spin-off from the Paul-Scherrer-Institute in Zurich, Switzerland, ...

Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine ...

Clinigen, the global speciality pharmaceutical services group, today announced that Equity Pharmaceuticals, part of the Clinigen Group, has entered into a new collaboration with Servier, an ...

The ALTAIR trial ultimately showed negative results in its question of whether adding trifluridine/tipiracil (TAS-102) would improve outcomes as compared with placebo in patients who were ctDNA or ...

The table is limited by our hospital pharmacy's formulary; however, our purpose was to update the current literature. The table is intended for use as a guide when medications labeled for ...

will support investigator-led projects exploring the potential of tipiracil/trifluridine (FTD/TPI) and futibatinib as therapeutic options for some of the most challenging cancer cases ...

compared to standard care with kinase inhibitor regorafenib and trifluridine and tipiracil chemotherapy. It's another setback for the LAG-3 category in MSS colorectal cancer, coming after Bristol ...

There is no approved treatment specifically for Mpox, however multiple approved antiviral agents for smallpox treatment were found to be useful in Mpox treatment and in the management of Mpox ...

Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days ...